Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.

MLA

Kim, Jihye, et al. “Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 29, no. 5, May 2020, pp. 999–1008. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-19-1389.

APA

Kim, J., Yuan, C., Babic, A., Bao, Y., Clish, C. B., Pollak, M. N., Amundadottir, L. T., Klein, A. P., Stolzenberg-Solomon, R. Z., Pandharipande, P. V., Brais, L. K., Welch, M. W., Ng, K., Giovannucci, E. L., Sesso, H. D., Manson, J. E., Stampfer, M. J., Fuchs, C. S., Wolpin, B. M., & Kraft, P. (2020). Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 29(5), 999–1008. https://doi.org/10.1158/1055-9965.EPI-19-1389

Chicago

Kim, Jihye, Chen Yuan, Ana Babic, Ying Bao, Clary B Clish, Michael N Pollak, Laufey T Amundadottir, et al. 2020. “Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 29 (5): 999–1008. doi:10.1158/1055-9965.EPI-19-1389.